-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: 2012 BIO International Convention
Americans, Biotech Execs, Convention Attendees Optimistic About Biotech
What does the future hold for biotechnology? After surveying American voters, biotech executives, and attendees here the 2012 BIO International Convention, we learned that the future is indeed bright. More than three quarters of American voters, nearly all the biotech execs, and 1,400 of the attendees we spoke to are optimistic that science and technology will find cures to help patients suffering from serious diseases, such as cancer, diabetes, Alzheimer’s, Parkinson’s and HIV/AIDS. Tempering that Read More >
An Insider’s View of the BioGENEius Challenge
By Erica Hiar, Environics A big highlight every year for many attendees at BIO International Convention is the announcement of the winner of the International BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of biotechnology through science research projects. But for me, the true excitement was the ride getting there. Four hundred thirty-five students applied for the U.S. International BioGENEius challenge and hundreds more applied to the Canadian and Western Read More >
Phase III Assets in High Demand – Results from the Business Forum Meeting Activity
At the BIO International Convention in Boston today, we released our results from the Business Forum meeting activity. This analysis provides a real-time snapshot of what in-licensors from pharma and biotech are looking for here at the conference. The Business Forum hit over 25,000 scheduled One-on-One Partnering™ meetings on Monday afternoon. This is 18% more meetings than last year, and more than double the meetings held back in 2007, when we last held this event in Read More >
What’s the Buzz?
Meet Deuteria Pharmaceuticals, winner of the 2012 Buzz of BIO competition. What is Buzz of BIO? Companies from around the world enter for the chance to win free registration and a company presentation in the BIO Business Forum. Who won? Deuteria Pharmaceuticals, Inc., a company that is pioneering ‘Deuterium-Enabled Chiral Switching’ (DECS) to improve the profile of drugs that interconvert between enantiomers both in vitro and in vivo. Stabilizing the preferred isomer improves the product Read More >
We Are BIO
Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >
Jim's Corner
Leave a comment
Email This Post
Tags: 2012 BIO International Convention, agricultural biotechnology, agriculture, BIO International Convention, business development, Health Care, International, PDUFA, prescription drugs, public policy, reimbursment, sbir, small business, TDP, Therapeutic Discovery Project
Tags: 2012 BIO International Convention, agricultural biotechnology, agriculture, BIO International Convention, business development, Health Care, International, PDUFA, prescription drugs, public policy, reimbursment, sbir, small business, TDP, Therapeutic Discovery Project
